SQZ Biotechnologies Company (SQZB)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -79.46 Million USD | -15.6% |
| 2021 | -68.74 Million USD | -36.06% |
| 2020 | -50.52 Million USD | -56.89% |
| 2019 | -32.2 Million USD | -59.15% |
| 2018 | -20.23 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -16.77 Million USD | 5.18% |
| 2023 Q1 | -17.68 Million USD | -30.56% |
| 2023 Q3 | -23.63 Million USD | -40.96% |
| 2022 FY | -79.46 Million USD | -15.6% |
| 2022 Q1 | -21.03 Million USD | -77.96% |
| 2022 Q4 | -13.54 Million USD | 40.17% |
| 2022 Q2 | -22.23 Million USD | -5.69% |
| 2022 Q3 | -22.64 Million USD | -1.83% |
| 2021 Q3 | -22.45 Million USD | 0.0% |
| 2021 FY | -68.74 Million USD | -36.06% |
| 2021 Q4 | -11.82 Million USD | 47.34% |
| 2020 FY | -50.52 Million USD | -56.89% |
| 2019 FY | -32.2 Million USD | -59.15% |
| 2018 FY | -20.23 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -5850.438% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -1037.99% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 249.992% |
| Nascent Biotech, Inc. | -2.08 Million USD | -3706.327% |
| Rebus Holdings, Inc. | -1.02 Million USD | -7690.588% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 222.003% |
| Qrons Inc. | -789.34 Thousand USD | -9967.055% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -12465.326% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -26.941% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -19025.876% |
| Skye Bioscience, Inc. | -37.64 Million USD | -111.089% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -6.004% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -1108.374% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -28964.893% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -2647.344% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -4264.888% |
| Mesoblast Limited | -87.95 Million USD | 9.655% |
| Marizyme, Inc. | -65.34 Million USD | -21.603% |
| Genus plc | 7.9 Million USD | 1105.873% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -629.58% |
| Pharming Group N.V. | -10.54 Million USD | -653.356% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -3562.249% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -2041.752% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -798.507% |
| ContraFect Corporation | -65.15 Million USD | -21.965% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1526.34% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -4500.062% |
| IMV Inc. | -36.48 Million USD | -117.795% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -885.945% |
| MultiCell Technologies, Inc. | -380.07 USD | -20907627.524% |
| ONE Bio Corp. | 8.67 Million USD | 1015.841% |
| Accustem Sciences Inc. | -3.74 Million USD | -2021.065% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -53.726% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -6171.16% |
| Q BioMed Inc. | -2.05 Million USD | -3772.339% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -2028.69% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -3237.603% |
| Biomind Labs Inc. | -1.21 Million USD | -6443.915% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -33.049% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -2461.894% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -905.48% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -3976.647% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -530508.974% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -400.673% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1266.006% |
| GB Sciences, Inc. | -1.36 Million USD | -5735.745% |
| Alpha Cognition Inc. | -13.77 Million USD | -476.973% |
| HST Global, Inc. | -146.21 Thousand USD | -54249.224% |
| CSL Limited | 2.64 Billion USD | 103.008% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -4428.454% |
| Halberd Corporation | -79.67 Thousand USD | -99633.922% |
| Enzolytics Inc. | -2.17 Million USD | -3550.442% |
| Agentix Corp. | -1.37 Million USD | -5682.518% |
| Resverlogix Corp. | -3.61 Million USD | -2101.219% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -2405.616% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 73.068% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 81185.714% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1247.562% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1900.104% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -2525.924% |
| AVAX Technologies, Inc. | -6.41 Million USD | -1138.983% |
| Zenith Capital Corp. | -10.59 Million USD | -649.943% |
| Genscript Biotech Corporation | -95.47 Million USD | 16.772% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -341798.288% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1816.672% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -131374.517% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -3863.064% |
| Kadimastem Ltd | -3.3 Million USD | -2302.614% |
| Helix BioMedix, Inc. | -1.05 Million USD | -7424.594% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1980.754% |
| BioStem Technologies, Inc. | -8.48 Million USD | -836.746% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -17903.983% |
| LadRx Corporation | 400.44 Thousand USD | 19944.023% |
| Cell Source, Inc. | -5.32 Million USD | -1393.344% |
| Regen BioPharma, Inc. | 1.02 Million USD | 7863.887% |
| Regen BioPharma, Inc. | 1.02 Million USD | 7863.887% |
| NovAccess Global Inc. | -4.76 Million USD | -1566.196% |
| Affymax, Inc. | -14.42 Million USD | -450.915% |
| Itoco Inc. | -1.86 Million USD | -4151.697% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1688.708% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -4661.174% |
| Mobile Lads Corp. | -2.26 Million USD | -3410.992% |
| CytoDyn Inc. | -49.84 Million USD | -59.435% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -100445.342% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -34733.229% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -8339.889% |
| SYBLEU INC | -180.3 Thousand USD | -43972.234% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -4827.276% |
| International Stem Cell Corporation | -131 Thousand USD | -60559.542% |
| Bioxytran, Inc. | -4.28 Million USD | -1756.635% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -146318.042% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -3040.563% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -65.302% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -3658.94% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -10076.12% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -2408.333% |
| Neutra Corp. | -233.46 Thousand USD | -33936.794% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -291.622% |
| PureTech Health plc | -65.69 Million USD | -20.955% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -273.657% |
| IXICO plc | -1.17 Million USD | -6645.671% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -700.484% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -39.098% |
| CSL Limited | 2.64 Billion USD | 103.008% |
| Cellectis S.A. | -103.17 Million USD | 22.98% |